Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 4 Grant or award Director acquired 12,500 shares (grant or award)
  2. 4 Grant or award Director acquired 12,500 shares (grant or award)
  3. 4 Grant or award SVP, Chief Development Officer acquired 194,300 shares (grant or award)
  4. 4 Other disposition SVP, Chief Development Officer disposed of 8,256 shares (other)
  5. 4 Other disposition President and CEO disposed of 28,289 shares (other)
  6. 4 Other disposition CFO disposed of 7,165 shares (other)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award President and CEO acquired 159,000 shares (grant or award)
  9. 4 Grant or award Director acquired 6,000 shares (grant or award)
  10. 4 Grant or award EVP, Gen. Counsel, Corp. Sec. acquired 35,000 shares (grant or award)
  11. 4 Grant or award Director acquired 6,000 shares (grant or award)
  12. 4 Grant or award Director acquired 6,000 shares (grant or award)
  13. 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
  14. 4 Grant or award Director acquired 6,000 shares (grant or award)
  15. 4 Grant or award Director acquired 6,000 shares (grant or award)
  16. 4 Grant or award CFO acquired 47,000 shares (grant or award)
  17. 4 Other disposition EVP, Gen. Counsel, Corp. Sec. disposed of 4,119 shares (other)
  18. 4 Other disposition President and CEO disposed of 12,268 shares (other)
  19. 4 Other disposition Chief Commercial Officer disposed of 1,082 shares (other)
  20. 4 Other disposition CFO disposed of 2,929 shares (other)

Page 2 of 22 · 436 filings